# Commission Regulation (EC) No 869/2005 of 8 June 2005 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards ivermectin and carprofen (Text with EEA relevance), Division 4.1.1: Arylpropionic acid derivative

Extent: E+W+S+N.I.

Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
‘Carprofen
Sum of carprofen and carprofen glucuronide conjugate
Bovine, equidae
500 μg/kg
Muscle
1 000 μg/kg
Fat
1 000 μg/kg
Liver
1 000 μg/kg
Kidney’

---
Source: https://www.legislation.gov.uk/eur/2005/869/annex/division/A/division/4/division/4.1/division/4.1.1 (the official version)
Page: https://openlegislation.uk/eu-regulation-2005-869/annex/division-A/division-4/division-4.1/division-4.1.1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.